Newleos Therapeutics is a Biotech company based in Boston. It has raised $93M in total funding. Latest round: Series A.
Newleos Therapeutics is a Biotech company based in Boston. Newleos Therapeutics has raised $93M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2025. The round record for Newleos Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Goldman Sachs Alternatives, Longwood Fund. 2 distinct backers are named across the disclosed rounds.
Totals shown for Newleos Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026